Bradley Hyman

Professor

Harvard University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Bradley Hyman is a faculty member at Harvard University in the United States. His research primarily focuses on Alzheimer's disease and related dementias, exploring mechanisms such as tau propagation, post-translational modifications, and the role of APOE in disease pathology. Recent publications address topics including tau aggregation, astrocyte involvement, and the heterogeneity of electronic health records in dementia research.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (5)

Cristian Lasagna-Reeves

Assistant Professor

Indiana University School of Medicine

UNITED STATES

View details

ALBERTO SERRANO-POZO

Assistant Professor of Neurology

Massachusetts General Hospital

UNITED STATES

View details

Mats Nilsson

Professor

Stockholm University

SWEDEN

View details

Rosemary Jackson

Academic, Principal Investigator (Teaching and Research) - (Tenure Track)

University of Dundee

UNITED KINGDOM

View details

Carlos Cruchaga

Assistant professor

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bradley Hyman

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Alzheimer disease-associated tau post-translational modification mimics impact tau propagation and uptake

Unsupervised Deep Learning of Electronic Health Records to Characterize Heterogeneity Across Alzheimer Disease and Related Dementias: Cross-Sectional Study

Interneuron diversity in the human dorsal striatum

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

TYK2 regulates tau levels, phosphorylation and aggregation in a tauopathy mouse model

Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription

Multifaceted roles of APOE in Alzheimer disease

Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer’s disease tau seeds have distinct properties

Reconstitution of the Alzheimer’s Disease Tau Core Structure from Recombinant Tau297–391 Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM

Reply: Soluble oligomers or insoluble fibrils?

Collaborators (5)

Cristian Lasagna-Reeves

ALBERTO SERRANO-POZO

Mats Nilsson

Rosemary Jackson

Carlos Cruchaga

Make your next move.